Skip to main content

Table 2 Factors associated with CD4+ T cells secreting cytokines in the univariate and multivariate linear regression analysis

From: Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B

Variable

CD4_IFN-γ

CD4_TNF-α

CD4_IL-2

Univariate (raw effects)

Multivariate (adjusted effects)

Univariate (raw effects)

Multivariate (adjusted effects)

Univariate (raw effects)

Multivariate (adjusted effects)

B (95% CI)

P

Adjusted B (95% CI)

Adjusted P

B (95% CI)

P

Adjusted B (95% CI)

Adjusted P

B (95% CI)

P

Adjusted B (95% CI)

Adjusted P

Age (≥ 25 vs <  25 years)

4.26 (1.15, 7.36)

0.008

4.09 (0.94, 7.24)

0.011

5.47 (−0.99, 11.93)

0.097

5.76 (− 0.52, 12.04)

0.072

0.11 (− 0.36, 0.58)

0.635

0.09 (− 0.42, 0.59)

0.729

Gender (Male ve Female)

2.35 (− 0.6, 5.3)

0.118

2.38 (− 0.55, 5.31)

0.110

5.48 (− 0.55, 11.52)

0.075

6.42 (0.57, 12.26)

0.032

0.22 (−0.22, 0.65)

0.334

0.13 (−0.34, 0.6)

0.586

Family History (Yes vs No)

0.56 (−2.14, 3.26)

0.684

0.55 (− 2.41, 3.51)

0.714

1.96 (−3.57, 7.48)

0.485

0.03 (−5.87, 5.94)

0.991

0.01 (−0.38, 0.41)

0.943

−0.03 (− 0.5, 0.44)

0.903

Vertical Transmission (Yes vs No)

−1.34 (−5, 2.33)

0.472

− 1.42 (− 5.41, 2.57)

0.483

2.05 (− 5.47, 9.57)

0.591

1.00 (−6.96, 8.97)

0.804

−0.01 (− 0.56, 0.53)

0.961

− 0.03 (− 0.67, 0.61)

0.931

Infection Time (≥ 20 vs <  20 years)

−0.2 (−4.01, 3.6)

0.917

−1.88 (− 5.74, 1.98)

0.336

0.85 (− 6.95, 8.64)

0.831

− 1.49 (−9.19, 6.2)

0.702

− 0.08 (− 0.65, 0.48)

0.769

−0.16 (− 0.77, 0.46)

0.616

Log HBsAg

0.60 (− 1.54, 2.75)

0.577

0.79 (− 1.35, 2.93)

0.466

0.004 (− 4.39–4.40)

0.999

0.42 (− 3.85, 4.68)

0.848

0.08 (− 0.24, 0.40)

0.621

0.01 (− 0.33, 0.36)

0.938

Log HBV DNA

0.09 (−0.45, 0.63)

0.741

−0.99 (− 2.09, 0.11)

0.078

1.45 (0.36–2.54)

0.010

−0.74 (− 2.94, 1.45)

0.505

0.26 (− 0.2, 0.72)

0.260

− 0.06 (− 0.24, 0.11)

0.483

HBeAg (Positive vs Negative)

1.18 (− 1.51, 3.87)

0.387

4.30 (− 0.10, 8.70)

0.055

7.18 (1.77, 12.58)

0.010

8.25 (−0.53, 17.03)

0.065

−0.22 (− 0.62, 0.17)

0.266

− 0.01 (− 0.72, 0.69)

0.969

ALT (<  2 ULN is the reference group)

 ≥ 2 & < 5 ULN

6.16 (2.76, 9.56)

0.000

6.77 (3.08, 10.46)

0.000

14.41 (7.64, 21.19)

0.000

13.08 (5.72, 20.44)

0.001

−0.14 (− 0.67, 0.38)

0.594

− 0.05 (− 0.64, 0.54)

0.859

 ≥ 5ULN

3.89 (− 0.34, 8.12)

0.072

3.82 (− 0.79, 8.44)

0.104

13.2 (4.77, 21.64)

0.002

9.08 (−0.12, 18.29)

0.053

0.20 (−0.45, 0.86)

0.539

0.23 (−0.51, 0.97)

0.533

Genotype (Genotype C is the reference group)

 B

−0.84 (−4.2, 2.53)

0.623

−0.14 (−3.42, 3.13)

0.930

−4.03 (−10.79, 2.73)

0.241

−2.5 (−9.04, 4.04)

0.451

− 0.52 (− 1.02, − 0.03)

0.039

−0.49 (− 1.02, 0.03)

0.067

 N

−0.85 (−5.43, 3.73)

0.715

− 2.39 (−7.83, 3.06)

0.388

− 9.19 (− 18.39, 0.01)

0.050

−6.88 (− 17.75, 3.99)

0.213

− 0.36 (− 1.04, 0.31)

0.288

− 0.59 (− 1.46, 0.28)

0.184

 O

−5.27 (− 10.98, 0.45)

0.071

−3.46 (− 9.08, 2.17)

0.226

−16.2 (− 27.68, − 4.72)

0.006

−11.84 (− 23.06, − 0.63)

0.039

− 0.68 (− 1.52, 0.16)

0.113

− 0.64 (− 1.54, 0.26)

0.161

  1. Significant values are shown in boldface. B: Unstandardized Coefficients. HBV genotype: Other included C + D, B + D, B + C, D; N, not detected
  2. ALT alanine aminotransferase, HBeAg HBV e antigen, HBsAg hepatitis B surface antigen